Candel gets busy IPO week moving with downsized raise as Rajiv Shukla’s third SPAC goes public

Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.

In a week that’s expected to see several biotechs price their IPOs, Candel Therapeutics got things kicked off Tuesday with a muted opener.

Paul Peter Tak

The company...

Click to view original post